Deborah Young to Anti-Obesity Agents
This is a "connection" page, showing publications Deborah Young has written about Anti-Obesity Agents.
Connection Strength
0.388
-
The long-term effectiveness of the anti-obesity medication phentermine (LEAP) trial: Rationale, design, and baseline characteristics. Contemp Clin Trials. 2026 Feb; 161:108219.
Score: 0.236
-
Antiobesity Medication Use in 2.2 Million Adults Across Eight Large Health Care Organizations: 2009-2015. Obesity (Silver Spring). 2019 12; 27(12):1975-1981.
Score: 0.153